Home care and nursing services in the lower mainland

Vaccinations for Pneumonia: Pneumovax 23 vs. Prevnar 13


Before we start, let’s clear up the confusion between the FDA and the CFIA

The U.S. Food and Drug Administration (FDA) signed an arrangement with the Canadian Food Inspection Agency (CFIA) and the Department of Health Canada(Health Canada) recognizing each other’s food safety systems as comparable to each other. May 4, 2016

The main difference between the two is the range of bacteria that they can help protect against. Pneumovax 23 protects against 23 types of pneumococcal bacteria, while Prevnar 13 protects against 13 types of pneumococcal bacteria. Oct 25, 2018

How long is the pneumococcal vaccine good for?

CDC, FDA and CFIA recommends 2 pneumococcal vaccines for all adults 65 years or older. You should receive a dose of PCV13 first, followed by a dose of PPSV23, at least 1 year later. If you already received any doses of PPSV23, get the dose of PCV13 at least 1 year after the most recent PPSV23 dose. Sep 17, 2018

How long do side effects of pneumonia vaccine last?

Side effects of the pneumococcal vaccine in adults and older children. Mild side effects of the pneumococcal polysaccharide vaccine (PPV) – the version of the pneumococcal vaccine given to adults and children over the age of two – include: low-grade fever between 98.6°F (37°C) and 100.4°F (38°C), mild irritation, redness, or swelling at the injection site that may last from one to 4 days.  Side effects may also vary based on how old you are when you’re injected.

Symptoms of Pneumonia:

The symptoms include problems with breathing, very high fever, pain in the chest, and a variety of respiratory issues. This is why this infection tends to be quite hazardous when children are affected by it. However, it also affects adults.

Prevnar 13 vs. pneumovax 23 vaccines: Who gets these vaccines?

Patients who have suffered from pneumonia in the past as well as people 50 or older, people with a past or present history of smoking, a history of asthma or COPD, or a history of immunocompromising conditions (e.g., diabetes, chronic kidney disease, HIV, hepatitis) need to get vaccinated. There are at the moment two vaccines which have been approved by the FDA and they are effective for the prevention of pneumococcal disease. The two vaccines are called Prevnar 13 and Pneumovax 23.

1  Cigarette smokers who are nineteen or over the age of nineteen

2  Candidates who are recipients of cochlear implants

3  People who are suffering from chronic liver disease

4  People who have undergone organ transplantation

5  People who are suffering from chronic problems and health conditions such as  COPD, nephrotic syndrome, renal failure, diabetes, and heart diseases

The CDC has also suggested that people who are over the age of 65 years must opt for the vaccine Pneumovax 23, even if they have received any other dose of vaccine for pneumonia.

How are these vaccines administered?

Pneumovax 23 can be administered intramuscularly or even subcutaneously. On the other hand, the vaccine Prevnar 13 should always be administered intramuscularly.

4 Responses to “Vaccinations for Pneumonia: Pneumovax 23 vs. Prevnar 13”

Join the conversation

Contact Us

Carol Wilmot, Director of Nursing
Phone: 604-781-4784

Laura Hart, Office Administrator
Phone: 604-789-5447